Best emollients for eczema (BEE) - comparing four types of emollients in children with eczema: protocol for randomised trial and nested qualitative study

被引:15
作者
Ridd, Matthew J. [1 ]
Wells, Sian [1 ]
Edwards, Louisa [2 ]
Santer, Miriam [3 ]
MacNeill, Stephanie [4 ]
Sanderson, Emily [4 ]
Sutton, Eileen [1 ]
Shaw, Alison R. G. [1 ]
Banks, Jonathan [5 ]
Garfield, Kirsty [4 ]
Roberts, Amanda [6 ]
Barrett, Tiffany J. [7 ]
Baxter, Helen [1 ]
Taylor, Jodi [4 ]
Lane, J. Athene [4 ]
Hay, Alastair D. [1 ]
Williams, Hywel C. [8 ]
Thomas, Kim Suzanne [8 ]
机构
[1] Univ Bristol, Bristol Med Sch, Ctr Acad Primary Care, Bristol, Avon, England
[2] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada
[3] Univ Southampton, Primary Care & Populat Sci, Southampton, Hants, England
[4] Univ Bristol, Bristol Randomised Trials Collaborat, Bristol Trials Ctr, Bristol, Avon, England
[5] Univ Hosp Bristol NHS Fdn, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Bristol, Avon, England
[6] Nottingham Support Grp Carers Children Eczema, Nottingham, England
[7] Univ Hosp Bristol NHS Fdn Trust, South West Med Informat & Training, Bristol, Avon, England
[8] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England
关键词
ATOPIC ECZEMA; OF-LIFE; SEVERITY; HEALTH; RESPONSIVENESS; DERMATITIS; CONSENSUS; POEM;
D O I
10.1136/bmjopen-2019-033387
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Atopic dermatitis/eczema affects around 20% of children and is characterised by inflamed, dry, itchy skin. Guidelines recommend 'leave-on' emollients that are applied directly to the skin to add or trap moisture and used regularly, they can soothe, enhance the skin barrier and may prevent disease 'flares'. However, the suitability of the many different emollients varies between people and there is little evidence to help prescribers and parents and carers decide which type to try first. Methods and analysis Design: pragmatic, multicentre, individually randomised, parallel group superiority trial of four types of emollient (lotions, creams, gel or ointments). Setting: general practitioner surgeries in England. Participants: children aged over 6 months and less than 12 years with mild-to-severe eczema and no known sensitivity to study emollients. Interventions: study-approved lotion, cream, gel or ointment as the only leave-on emollient for 16 weeks, with directions to apply twice daily and as required. Other treatments, such as topical corticosteroids, used as standard care. Follow-up: 52 weeks. Primary outcome: validated patient-orientated eczema measure measured weekly for 16 weeks. Secondary outcomes: eczema signs (Eczema Area Severity Index) by masked researcher, treatment use, parent satisfaction, adverse events, child and family quality of life (Atopic Dermatitis Quality of Life, Child Health Utility 9D and Dermatitis Family Impact). Sample size: 520 participants (130 per group). Analysis: intention-to-treat using linear mixed models for repeated measures. Nested qualitative study: audio-recording of sample of baseline appointments and up to 60 interviews with participants at 4 and 16 weeks, interviews to be transcribed and analysed thematically.
引用
收藏
页数:10
相关论文
共 32 条
[1]   Assessment of blinding in clinical trials [J].
Bang, HJ ;
Ni, LY ;
Davis, CE .
CONTROLLED CLINICAL TRIALS, 2004, 25 (02) :143-156
[2]   The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema [J].
Batchelor, J. M. ;
Ridd, M. J. ;
Clarke, T. ;
Ahmed, A. ;
Cox, M. ;
Crowe, S. ;
Howard, M. ;
Lawton, S. ;
McPhee, M. ;
Rani, A. ;
Ravenscroft, J. C. ;
Roberts, A. ;
Thomas, K. S. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (03) :577-582
[3]   Quality of life and disease severity are correlated in children with atopic dermatitis [J].
Ben-Gashir, MA ;
Seed, PT ;
Hay, RJ .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (02) :284-290
[4]  
Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]
[5]   Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension [J].
Calvert, Melanie ;
Blazeby, Jane ;
Altman, Douglas G. ;
Revicki, Dennis A. ;
Moher, David ;
Brundage, Michael D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08) :814-822
[6]   Emollient prescribing formularies in England and Wales: a cross-sectional study [J].
Chan, Jonathan P. ;
Boyd, Grace ;
Quinn, Patrick A. ;
Ridd, Matthew J. .
BMJ OPEN, 2018, 8 (06)
[7]   Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods [J].
Charman, C. R. ;
Venn, A. J. ;
Ravenscroft, J. C. ;
Williams, H. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) :1326-1332
[8]   The patient-oriented eczema measure - Development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective [J].
Charman, CR ;
Venn, AJ ;
Williams, HC .
ARCHIVES OF DERMATOLOGY, 2004, 140 (12) :1513-1519
[9]  
Emerson RM, 1998, BRIT J DERMATOL, V139, P73
[10]   The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference [J].
Gaunt, D. M. ;
Metcalfe, C. ;
Ridd, M. .
ALLERGY, 2016, 71 (11) :1620-1625